Icosabutate, formerly known as PRB-01022 and PRC-4016, is a PPAR agonist potentially for the treatment of hypertriglyceridemia. References: Kastelein JJ, Hallén J, Vige R, Fraser DA, Zhou R, Hustvedt SO, Orloff DG, Bays HE. Icosabutate, a Structurally Engineered Fatty Acid, Improves the Cardiovascular Risk Profile in Statin-Treated Patients with Residual Hypertriglyceridemia. Cardiology. 2016;135(1):3-12. doi: 10.1159/000445047. PubMed PMID: 27160246.

纯度：≥98%

CAS：1253909-57-7